Regeneron Pharmaceuticals, Inc.(REGN)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
REGN | 69.71 B | 16.52x | 19.00% | 29.65% | $40.97 | 14.55% | 8.61 | 60.00% | $818.90 | $518.16 |
AMGN | 197.69 B | 25.47x | 5.80% | 20.96% | $14.38 | 1.01% | 6.24 | 2.78% | $388.36 | $264.02 |
VRTX | 123.26 B | 28.84x | 7.80% | 35.51% | $16.84 | 24.20% | 0.10 | - | $507.92 | $362.50 |
Peer Valuation & Performance Analysis
Peer group analysis for Regeneron Pharmaceuticals, Inc. (REGN) compared to its primary competitors (including AMGN, VRTX) reveals distinct metrics. REGN trades at a valuation discount relative to its competitors, with a P/E ratio of 16.5x versus the peer average of 27.2x (representing a 39% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, REGN's revenue growth of 19.0% exceeds the peer average of 6.8%, highlighting its competitive strength and market share gains. Additionally, its net margin of 29.6% is comparable to the peer average of 28.2%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• REGN ranks #1 in P/E ratio, #1 in revenue growth, and #2 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $676.05 | $691.13 | $672.31 | $676.69 | 648,300 | +0.09% |
| 2026-07-16 | $666.28 | $680.29 | $661.38 | $678.94 | 730,100 | +1.90% |
| 2026-07-15 | $656.11 | $669.10 | $648.66 | $664.45 | 555,400 | +1.27% |
| 2026-07-14 | $658.00 | $663.10 | $653.31 | $656.12 | 478,000 | -0.29% |
| 2026-07-13 | $661.63 | $665.60 | $655.11 | $663.09 | 606,300 | +0.22% |
| 2026-07-10 | $670.06 | $676.66 | $658.50 | $664.52 | 581,700 | -0.83% |
| 2026-07-09 | $660.80 | $669.16 | $660.80 | $667.95 | 672,000 | +1.08% |
| 2026-07-08 | $669.11 | $670.35 | $661.43 | $662.88 | 746,800 | -0.93% |
| 2026-07-07 | $663.18 | $677.92 | $659.02 | $676.23 | 918,700 | +1.97% |
| 2026-07-06 | $657.96 | $657.96 | $637.72 | $649.81 | 714,300 | -1.24% |
| 2026-07-02 | $630.52 | $654.94 | $625.70 | $654.27 | 1,071,600 | +3.77% |
| 2026-07-01 | $629.90 | $632.85 | $623.89 | $624.72 | 1,170,600 | -0.82% |
| 2026-06-30 | $630.95 | $634.06 | $622.29 | $623.54 | 820,900 | -1.17% |
| 2026-06-29 | $635.99 | $638.30 | $626.86 | $631.81 | 734,400 | -0.66% |
| 2026-06-26 | $623.64 | $638.76 | $623.44 | $632.90 | 1,213,600 | +1.48% |